PEROSPHERE TECHNOLOGIES INC.

Danbury, CT · Medtech · Private

Automated microfluidic point-of-care coagulometer device using silicon/glass cuvettes and near-infrared light detection to measure blood clotting time

Claim this profile

Follows are private to you and power your alerts

Updated · perospheretech.com

Sector
Medtech
Headquarters
Danbury, CT
Latest Form D
$7.5M, Jan 2024
Total capital
$9.4M
Federal grants
$2M
2 awards · 2023–2024
Rank in peer group#62 of 477
Private capital raised
$7.5M
1 Form D · last Jan 2024
34 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
7 pending · first 2020
Rank in peer group#49 of 477

Capital timeline

20232024FEDERAL ↑EQUITY ↓Cumulative $9.4M$1.1M$898K1st Form D$7.5M
20232024FEDERAL ↑EQUITY ↓Cumulative $9.4M$1.1M$898K1st Form D$7.5M

Latest events

  • Federal grantHealth and Human S · Phase II · Novel Broad-Spectrum Point-of-Care Coagulometer$898K
  • Private capital raisedForm D · SEC · 1st filing$7.5M
  • Federal grantHealth and Human S · Phase II · Novel Broad-Spectrum Point-of-Care Coagulometer$1.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

4months

from PEROSPHERE TECHNOLOGIES INC.’s first federal award to its first private round.

First federal award · Sep 2023
Health and Human S · $1.1M
First Form D · Jan 2024
$7.5M · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#62 · top 13%
  • Granted patents#49 · top 10%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Bakhru SashaResearcherExecutive Officer, DirectorLinked by 5 patents · $898K in grants as PI
  • Daryl MootooExecutive OfficerNamed in SEC Form D filings
  • Kevin CrowleyDirectorNamed in SEC Form D filings
  • Mark PavaoDirectorNamed in SEC Form D filings
  • Michelle BrennanDirectorNamed in SEC Form D filings
  • Solomon SteinerDirectorNamed in SEC Form D filings
Show all 7 people
  • Steve WardExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 13
Show all 13 patent records
  • Whole Blood Control Sample Systems And Method Of Preparing And Using The SameJun 18, 2026 · Application 19536479Pending
  • Whole Blood Control Sample Systems And Method Of Preparing And Using The SameFeb 17, 2026 · US 12,553,907Granted
  • CoagulometerApr 15, 2025 · US D1,071,223Granted
  • Microfluidic Chip-based, Universal Coagulation AssayMar 14, 2024 · Application 18512673Pending
  • Microfluidic Chip-based, Universal Coagulation AssayDec 26, 2023 · US 11,852,639Granted
  • CoagulometerSep 20, 2022 · US D,964,569Granted
  • Microfluidic Chip-based, Universal Coagulation AssayFeb 8, 2022 · US 11,243,219Granted
  • Methods For Effectively And Rapidly Desensitizing Allergic PatientsApr 30, 2020 · Application 16144450Pending
  • Microfluidic Chip-based, Universal Coagulation AssayJan 14, 2020 · US 10,534,006Granted
  • Whole Blood Control Sample Systems And Method Of Preparing And Using The SameApplication 63014852Pending
  • Whole Blood Control Sample Systems And Method Of Preparing And Using The SameApplication PCTUS2021028615Pending
  • A Method Of Measuring Lysis Time In Wholeblood Or Plasma And Methods Of Improving Treatment Of Patients Administered Fibrinolytic Altering Drugs Using Lysis TimeApplication PCTUS2025028849Pending
  • Method Of Measuring Lysis Time In Wholeblood Or Plasma And Methods Of Improving Treatment Of Patients Administered Fibrinolytic Altering Drugs Using Lysis TimeApplication 63647311Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .